CHME OTC
China Medicine Corp.
1W: -21.3%
1M: -52.1%
3M: +51.2%
YTD: -4.6%
1Y: +2483.3%
3Y: +30900.0%
5Y: +55.0%
$0.03
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$17M
+302.9% ▲
5Y CAGR: +46.1%
Capital Expenditures
$4M
-37.8% ▼
5Y CAGR: +234.9%
Free Cash Flow
$13M
+761.0% ▲
5Y CAGR: +39.2%
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$2M
+22.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2005 | FY2006 | FY2007 | FY2008 | FY2009 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$32K | $5M | $7M | $9M | $1M |
| Depreciation & Amort. | $0 | $162K | $784K | $421K | $1M |
| Stock-Based Comp. | $0 | $0 | $0 | $88K | $131K |
| Change in Working Capital | $0 | -$8M | -$10M | -$5M | $7M |
| Other Non-Cash Items | $0 | $787K | $103K | -$118K | $7M |
| Operating Cash Flow | -$32K | -$2M | -$2M | $4M | $17M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | -$826K | -$390K | -$3M | -$4M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | -$8M |
| Investment Purchases | $0 | $0 | $0 | -$5M | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | -$2M |
| Investing Cash Flow | $0 | -$826K | -$390K | -$8M | -$14M |
| — Financing Activities — | |||||
| Net Debt Issuance | $95K | -$94K | $0 | $0 | -$4M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$2M | -$200K | $0 | $362K | -$2M |
| Financing Cash Flow | $34K | $3M | $8M | $362K | -$6M |
| Net Change in Cash | $2K | $280K | $5M | -$3M | -$2M |
| Cash End of Period | $2K | $371K | $6M | $3M | $472K |
| Free Cash Flow | -$32K | -$3M | -$3M | $2M | $13M |